Latest California Healthline Stories
Biden Pick to Lead NIH Finally Has Her Day, but Still Gets Caught Up in Drug Price Debate
Monica Bertagnolli, the president’s choice to head the National Institutes of Health, appeared before a Senate committee this week. Her confirmation has been held up by Sen. Bernie Sanders (I-Vt.), who has demanded President Joe Biden work more aggressively to lower prescription drug prices.
The NIH Ices a Research Project. Is It Self-Censorship?
The National Institutes of Health appeared to be digging into health misinformation. But then the federal agency stepped back. It can’t quite explain why, sometimes even offering contradictory explanations.
KFF Health News' 'What the Health?': Congress Is Out. The Presidential Campaign Is In.
Congress is in recess until after Labor Day, and lawmakers won’t have much time when they return to get the government funded before the next fiscal year. Meanwhile, the Republican campaign for president has begun in earnest, and while repealing the Affordable Care Act is no longer the top promise, some candidates have lively ideas about what to do with federal health programs. Alice Miranda Ollstein of Politico, Sandhya Raman of CQ Roll Call, and Lauren Weber of The Washington Post join KFF Health News’ chief Washington correspondent, Julie Rovner, to discuss these issues and more. Also this week, Rovner interviews KFF Health News’ Phil Galewitz, who reported the latest KFF Health News-NPR “Bill of the Month,” about how a bill that should never have been sent created headaches for one patient.
KFF Health News' 'What the Health?': Let’s Talk About the Weather
2023 will likely be remembered as the summer Arizona sizzled, Vermont got swamped, and nearly the entire Eastern Seaboard, along with huge swaths of the Midwest, choked on wildfire smoke from Canada. Still, none of that has been enough to prompt policymakers in Washington to act on climate issues. Meanwhile, at a public court hearing, […]
Watch: Beyond the Script of ‘The G Word’ and How Government Responds to Disease (Or Not)
KHN Editor-in-Chief Elisabeth Rosenthal joins comedian Adam Conover to discuss his new Netflix series, “The G Word,” which examines the federal government’s role in Americans’ lives, and how it plays out in the covid era.
Why Cheap, Older Drugs That Might Treat Covid Never Get Out of the Lab
The hydroxychloroquine and ivermectin fiascoes have soured many doctors on repurposing drugs for covid. A few inexpensive old drugs may be as good as some of the new antivirals, but they face complex obstacles to get to patients.
KHN’s ‘What the Health?’: Funding for the Next Pandemic
In his proposed budget, President Joe Biden called for a boost in health spending that includes billions of dollars to prepare for a future pandemic. But that doesn’t include money he says is needed immediately for testing and treating covid-19. Also this week, federal regulators authorized a second booster shot for people 50 and older yet gave little guidance to consumers about who needs the shot and when. Amy Goldstein of The Washington Post, Jennifer Haberkorn of the Los Angeles Times, and Rachana Pradhan of KHN join KHN’s Mary Agnes Carey to discuss these issues and more. Plus, Julie Rovner interviews KHN’s Julie Appleby, who reported and wrote the latest KHN-NPR “Bill of the Month” episode about a very expensive air ambulance ride.
KHN’s ‘What the Health?’: Congress Shelves Covid Funding for Now
The Biden administration’s request for billions more in funding to fight covid-19 hit a snag on Capitol Hill this week, as Democrats objected to Republican demands that money allocated to states but not yet spent be reclaimed. Meanwhile, the big annual spending bill about to cross the finish line addresses other health policy changes, such as giving the FDA authority to regulate “synthetic” nicotine. Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, Rachel Cohrs of Stat, and Jessie Hellmann of Modern Healthcare join KHN’s Julie Rovner to discuss these issues and more. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read, too.
Why Pregnant People Were Left Behind While Vaccines Moved at ‘Warp Speed’ to Help the Masses
Clinical trials of covid-19 vaccines excluded pregnant people, which left many women wondering whether to get vaccinated.
Wartime Trauma Hits Close to Home for Scholar of Dementia
The federal government is putting up $7.2 million for a study into the correlation between war trauma and dementia in Vietnamese immigrants. Oahn Meyer, an associate professor at the University of California-Davis who is leading the study, wonders whether her mother’s dementia is linked to trauma she suffered during the Vietnam War.